Skip to main content
Recent Activity:
Displaying 1 - 11 of 11

Washington, D.C. – Today, House Judiciary Committee Chairman Jerrold Nadler (D-NY) delivered the following opening remarks, as prepared, during the markup of H.R. 6196, the Trademark Modernization Act of 2020:

"H.R. 6196, the Trademark Modernization Act of 2020, is a bipartisan bill that will modernize trademark law to reflect technological advances, improve the efficiency of trademark registration, and address recent threats to the proper functioning of the U.S. trademark system.

Washington, D.C. – Yesterday, House Judiciary Committee Chairman Jerrold Nadler (D-NY-10) joined Representative Lucy McBath (D-GA-06) in applauding the House passage of H.R. 7259, the Patents for Humanity Program Improvement Act. The legislation, introduced by Rep. McBath earlier this month,strengthens incentives for innovators to use their talents to solve global humanitarian challenges, and is co-sponsored by Rep. Ben Cline (R-VA-06), Rep. Hank Johnson (D-GA-04), who Chairs the House Judiciary Subcommittee on Courts, Intellectual Property, and the Internet, and Rep. Martha Roby (R-AL-02), Ranking Republican Member on the Subcommittee.

Washington, D.C. –Today, House Judiciary Committee Chairman Jerrold Nadler (D-NY) delivered the following opening remarks during the markup of H.R. 3991, the Affordable Prescriptions for Patients Through Improvements to Patent Litigation Act of 2019:

"H.R. 3991, the 'Affordable Prescriptions for Patients Through Improvements to Patent Litigation Act of 2019,' is the second bipartisan measure we are considering today that aims to stem the tide of rising medical costs and make healthcare more affordable.

Washington, D.C. –Today, House Judiciary Committee Chairman Jerrold Nadler (D-NY) delivered the following opening remarks during the markup of H.R. 5133, the Affordable Prescriptions for Patients Through Promoting Competition Act of 2019:

"H.R. 5133, the 'Affordable Prescriptions for Patients Through Promoting Competition Act of 2019,' is one of two bipartisan measures that we are considering today as part of the Committee's efforts to lower the soaring cost of prescription drugs and deliver more affordable healthcare for consumers.

Today, House Judiciary Committee Chairman Jerrold Nadler (D-NY) delivered the following opening statement for the Subcommittee on Courts, Intellectual Property, and the Internet hearing on "The Patent Trial and Appeal Board and the Appointments Clause: Implications of Recent Court Decisions":

2141 Rayburn House Office Building, Washington, DC 20515

Witnesses

John F. Duffy
Samuel H. McCoy II Professor of Law, University of Virginia School of Law

2141 Rayburn House Office Building, Washington, DC 20515

Witnesses

Panel One:

Mary Boney Denison
Commissioner for Trademarks, U.S. Patent and Trademark Office

Today, House Judiciary Committee Chairman Jerrold Nadler (D-NY) delivered the following opening remarks during a Subcommittee on Courts, Intellectual Property, and the Internet hearing on oversight of the U.S. Patent and Trademark Office:

2141 Rayburn House Office Building, Washington, DC 20515

Witnesses

The Honorable Andrei Ianci
Under Secretary for Intellectual Property and Director of the U.S. Patent and Trademark Office, U.S. Patent and Trademark Office

2141 Rayburn House Office Building, Washington, DC 20515

Witnesses

Ms. Susie Armstrong
Senior Vice President, Engineering, Qualcomm, Inc.

Today, Congressman Jerrold Nadler (D-NY), Chairman of the House Judiciary Committee, delivered the following opening remarks at the House Judiciary Committee organizational meeting: